SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $83,001 | -19.8% | 3,590 | -9.0% | 0.05% | -18.0% |
Q2 2023 | $103,464 | -6.8% | 3,946 | -8.5% | 0.06% | 0.0% |
Q1 2023 | $111,042 | -28.6% | 4,314 | -27.8% | 0.06% | -24.7% |
Q4 2022 | $155,488 | +5.8% | 5,978 | +16.1% | 0.08% | +37.3% |
Q3 2022 | $147,000 | +16.7% | 5,151 | +0.8% | 0.06% | +25.5% |
Q2 2022 | $126,000 | -2.3% | 5,111 | +123.4% | 0.05% | -19.0% |
Q1 2022 | $129,000 | -14.0% | 2,288 | -5.6% | 0.06% | +1.8% |
Q4 2021 | $150,000 | -10.2% | 2,425 | -8.1% | 0.06% | -21.9% |
Q3 2021 | $167,000 | -27.1% | 2,640 | -4.8% | 0.07% | -22.3% |
Q2 2021 | $229,000 | -22.4% | 2,774 | -30.8% | 0.09% | -24.8% |
Q1 2021 | $295,000 | +3.1% | 4,006 | +1.7% | 0.12% | +5.0% |
Q4 2020 | $286,000 | -16.4% | 3,940 | -45.0% | 0.12% | -33.5% |
Q3 2020 | $342,000 | 0.0% | 7,168 | -12.0% | 0.18% | +10.5% |
Q2 2020 | $342,000 | +1.8% | 8,149 | -34.5% | 0.16% | +17.4% |
Q1 2020 | $336,000 | -38.8% | 12,448 | -12.7% | 0.14% | +53.3% |
Q4 2019 | $549,000 | – | 14,253 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |